Larger study confirms statins' role in preventing cardiac events

October 5, 2012
Larger study confirms statins' role in preventing cardiac events
A large and unselected community-based study has confirmed the results of randomized controlled trials that have found persistent statin use to be beneficial for the primary prevention of acute cardiac events; the study was published online Sept. 27 in The American Journal of Cardiology.

(HealthDay)—A large and unselected community-based study has confirmed the results of randomized controlled trials that have found persistent statin use to be beneficial for the primary prevention of acute cardiac events; the study was published online Sept. 27 in The American Journal of Cardiology.

Varda Shalev, M.D., from Tel Aviv University in Israel, and colleagues examined the effectiveness of in primary prevention of acute nonfatal in the community setting. Data were analyzed from a cohort of 171,535 adults aged 45 to 75 years, without cardiovascular disease, who were given statins between 1998 to 2009 in a large health maintenance organization in Israel.

The researchers found that the incidence of acute cardiovascular events during the 993,519 person-years of follow-up was 10.22 per 1,000 person-years. Persistence with statins correlated with significantly reduced risk of incident cardiac events. There was a hazard ratio of 0.58 for the most persistent users (covered with statins for 80 percent or more of their follow-up time) compared with non-persistent users (less than 20 percent of days covered). When the analyses were limited to patients with more than five years of follow-up, the results were similar. Treatment with high efficacy statins correlated with a reduced risk of cardiac events.

"In conclusion, our large and unselected community-based study supports the results of regarding the beneficial effect of statins in the primary prevention of acute cardiac events," the authors write.

Explore further: Non-HDL-C level associated with risk of major cardiovascular events among patients taking statins

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Cardiovascular risk counseling improves statin adherence

May 31, 2012

(HealthDay) -- For patients taking statins for prevention of cardiovascular disease (CVD), extended care with nurse-led cardiovascular risk-factor counseling improves statin adherence and reduces anxiety, with improvements ...

Statins are unlikely to prevent blood clots, analysis finds

September 18, 2012

Despite previous studies suggesting the contrary, statins (cholesterol-lowering drugs) may not prevent blood clots (venous thrombo-embolism) in adults, according to a large analysis by international researchers published ...

Recommended for you

Heart attack treatment hypothesis 'busted'

July 6, 2015

Researchers have long had reason to hope that blocking the flow of calcium into the mitochondria of heart and brain cells could be one way to prevent damage caused by heart attacks and strokes. But in a study of mice engineered ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

alfie_null
not rated yet Oct 06, 2012
Since it wasn't mentioned, should I assume the authors have never had any relation with pharma that manufactures statins?
Doug_Huffman
not rated yet Oct 06, 2012
=Null, it'll cost YOU US$32 to find out. Journal format requires conflict of interest notice in the full text. Never ass-u-me anything.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.